147 related articles for article (PubMed ID: 20020526)
1. Effect of altered AGP plasma binding on heart rate changes by S(-)-propranolol in rats using mechanism-based estimations of in vivo receptor affinity (K(B,vivo)).
van Steeg TJ; Krekels EH; Freijer J; Danhof M; de Lange EC
J Pharm Sci; 2010 May; 99(5):2511-20. PubMed ID: 20020526
[TBL] [Abstract][Full Text] [Related]
2. Influence of plasma protein binding on pharmacodynamics: Estimation of in vivo receptor affinities of beta blockers using a new mechanism-based PK-PD modelling approach.
van Steeg TJ; Boralli VB; Krekels EH; Slijkerman P; Freijer J; Danhof M; de Lange EC
J Pharm Sci; 2009 Oct; 98(10):3816-28. PubMed ID: 19117045
[TBL] [Abstract][Full Text] [Related]
3. Effect of altered plasma protein binding on pharmacokinetics and pharmacodynamics of propranolol in rats after surgery: role of alpha-1-acid glycoprotein.
Yasuhara M; Fujiwara J; Kitade S; Katayama H; Okumura K; Hori R
J Pharmacol Exp Ther; 1985 Nov; 235(2):513-20. PubMed ID: 2997437
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic-pharmacodynamic modelling of S(-)-atenolol in rats: reduction of isoprenaline-induced tachycardia as a continuous pharmacodynamic endpoint.
van Steeg TJ; Freijer J; Danhof M; de Lange EC
Br J Pharmacol; 2007 Jun; 151(3):356-66. PubMed ID: 17420778
[TBL] [Abstract][Full Text] [Related]
5. Reproducible and time-dependent modification of serum protein binding in Wistar Kyoto rats.
van Steeg TJ; Krekels EH; Danhof M; de Lange EC
J Pharmacol Toxicol Methods; 2007; 56(1):72-8. PubMed ID: 17376707
[TBL] [Abstract][Full Text] [Related]
6. Mechanism-based pharmacodynamic modeling of S(-)-atenolol: estimation of in vivo affinity for the beta1-adrenoceptor with an agonist-antagonist interaction model.
van Steeg TJ; Freijer J; Danhof M; de Lange EC
J Pharmacol Exp Ther; 2008 Mar; 324(3):1234-42. PubMed ID: 18162599
[TBL] [Abstract][Full Text] [Related]
7. Concentration-effect relationship of l-propranolol and metoprolol in spontaneous hypertensive rats after exercise-induced tachycardia.
Brynne L; Karlsson MO; Paalzow LK
J Pharmacol Exp Ther; 1998 Sep; 286(3):1152-8. PubMed ID: 9732372
[TBL] [Abstract][Full Text] [Related]
8. Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man.
Coltart DJ; Shand DG
Br Med J; 1970 Sep; 3(5725):731-4. PubMed ID: 4394650
[TBL] [Abstract][Full Text] [Related]
9. Mechanism-based modeling of rebound tachycardia after chronic l-propranolol infusion in spontaneous hypertensive rats.
Brynne L; Paalzow LK; Karlsson MO
J Pharmacol Exp Ther; 1999 Aug; 290(2):664-71. PubMed ID: 10411576
[TBL] [Abstract][Full Text] [Related]
10. Propranolol increases the threshold for lidocaine-induced convulsions in awake rats: a direct effect on the brain.
Nakamura T; Oda Y; Takahashi R; Tanaka K; Hase I; Asada A
Anesth Analg; 2008 May; 106(5):1450-5, table of contents. PubMed ID: 18420859
[TBL] [Abstract][Full Text] [Related]
11. Binding to serum alpha 1-acid glycoprotein and effect of beta-adrenoceptor antagonists in rats with inflammation.
Belpaire FM; Bogaert MG; Mugabo P; Rosseel MT
Br J Pharmacol; 1986 Jul; 88(3):697-705. PubMed ID: 2874859
[TBL] [Abstract][Full Text] [Related]
12. Pravastatin reverses the down-regulating effect of inflammation on beta-adrenergic receptors: a disease-drug interaction between inflammation, pravastatin, and propranolol.
Clements JD; Jamali F
Vascul Pharmacol; 2007 Jan; 46(1):52-9. PubMed ID: 16949884
[TBL] [Abstract][Full Text] [Related]
13. The beta-adrenoceptor subtype(s) mediating adrenaline- and dobutamine-induced blood pressure and heart rate changes in healthy volunteers.
Daul A; Hermes U; Schäfers RF; Wenzel R; von Birgelen C; Brodde OE
Int J Clin Pharmacol Ther; 1995 Mar; 33(3):140-8. PubMed ID: 7599912
[TBL] [Abstract][Full Text] [Related]
14. Altered pharmacokinetics of a novel anticancer drug, UCN-01, caused by specific high affinity binding to alpha1-acid glycoprotein in humans.
Fuse E; Tanii H; Takai K; Asanome K; Kurata N; Kobayashi H; Kuwabara T; Kobayashi S; Sugiyama Y
Cancer Res; 1999 Mar; 59(5):1054-60. PubMed ID: 10070963
[TBL] [Abstract][Full Text] [Related]
15. Consequence of exercise on the cardiovascular effects of l-propranolol in spontaneously hypertensive rats.
Brynne L; Paalzow LK; Karlsson MO
J Pharmacol Exp Ther; 2000 Sep; 294(3):1201-8. PubMed ID: 10945878
[TBL] [Abstract][Full Text] [Related]
16. Alpha-1 Acid Glycoprotein as a Biomarker for Subclinical Illness and Altered Drug Binding in Rats.
Boyle CA; Coatney RW; Wickham A; Mukherjee SK; Meunier LD
Comp Med; 2021 Apr; 71(2):123-132. PubMed ID: 33789781
[TBL] [Abstract][Full Text] [Related]
17. Effect of sialic acid residues of human alpha 1-acid glycoprotein on stereoselectivity in basic drug-protein binding.
Shiono H; Shibukawa A; Kuroda Y; Nakagawa T
Chirality; 1997; 9(3):291-6. PubMed ID: 9176995
[TBL] [Abstract][Full Text] [Related]
18. Comparison of propranolol-binding plasma proteins in sheep with those in humans, dogs and rats.
Hill MD; Briscoe PR; Abramson FP
Biochem Pharmacol; 1989 Dec; 38(23):4199-205. PubMed ID: 2557042
[TBL] [Abstract][Full Text] [Related]
19. Plasma binding and the affinity of propranolol for a beta receptor in man.
McDevitt DG; Frisk-Holmberg M; Hollifield JW; Shand DG
Clin Pharmacol Ther; 1976 Aug; 20(2):152-7. PubMed ID: 947650
[TBL] [Abstract][Full Text] [Related]
20. Association of in vivo and in vitro propranolol levels in canine Purkinje fibers with antiarrhythmic effects.
Pruett JK; Walle T; Bagwell EE
J Pharmacol Exp Ther; 1977 Jul; 202(1):45-54. PubMed ID: 17729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
